Understanding and Preventing Placenta-Mediated Pregnancy Complications
ContributorsSkeith, Leslie; Blondon, Marc; Ní Áinle, Fionnuala
Published inHämostaseologie, vol. 40, no. 3, p. 356-363
Publication date2020-08
First online date2020-07-29
Abstract
Keywords
- Abruptio Placentae / epidemiology
- Adult
- Antibodies, Antiphospholipid / blood
- Anticoagulants / therapeutic use
- Antiphospholipid Syndrome / complications
- Antiphospholipid Syndrome / diagnosis
- Antiphospholipid Syndrome / drug therapy
- Aspirin / therapeutic use
- Female
- Fetal Growth Retardation / epidemiology
- Fetal Mortality / trends
- Heparin, Low-Molecular-Weight / therapeutic use
- Humans
- Placenta / pathology
- Platelet Aggregation Inhibitors / therapeutic use
- Pre-Eclampsia / epidemiology
- Pre-Eclampsia / etiology
- Pre-Eclampsia / prevention & control
- Pregnancy
- Pregnancy Complications / etiology
- Pregnancy Complications / physiopathology
- Pregnancy Complications / prevention & control
- Risk Factors
- Thrombophilia / complications
- Thrombophilia / diagnosis
- Thrombophilia / drug therapy
Affiliation
Research group
Citation (ISO format)
SKEITH, Leslie, BLONDON, Marc, NÍ ÁINLE, Fionnuala. Understanding and Preventing Placenta-Mediated Pregnancy Complications. In: Hämostaseologie, 2020, vol. 40, n° 3, p. 356–363. doi: 10.1055/a-1184-8388
Main files (1)
Article (Published version)
Identifiers
- PID : unige:161665
- DOI : 10.1055/a-1184-8388
- PMID : 32726830
ISSN of the journal0720-9355